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Both in the UK and more widely, the higher education
sector is under pressure from the government to
demonstrate that it makes a difference. That aside, few
of us want to be the kind of academic that sits in an
ivory tower thinking clever thoughts while Rome burns
below. As Karl Marx said, many academics only inter-
pret the world, but the true purpose of scholarship is to
change it. The ‘impact agenda’ thus contains two goals
that may occasionally be in tension with one another.
The first is to demonstrate impact as defined by a rela-
tively narrow set of government-driven criteria and
metrics (most notably in the UK, the ‘Impact’ section of
the Research Excellence Framework). There is much
emphasis in policy circles, for example, on the need for
medical schools to build links with industry with a view
to generating ‘health and wealth’ (that is, improving sur-
vival or quality of life while also saving money and
boosting business for our national industries). The sec-
ond goal, more in line with the vision of engaged scho-
larship articulated by Marx, is to align the research
agenda with such things as community-campus partner-
ships and a commitment to social justice. Whilst it is
easy to be cynical about the colonisation of academia by
commercial interests, many universities now boast fruit-
ful industry collaborations that have not only supported
the development of new drugs, devices and technologies
(and, in a few cases, led to measurable economic benefit
for the university) but which have also accelerated the
uptake and use of innovations for societal benefit. Never-
theless, much of the impact from biomedical research to
date has been through a wide range of non-commercial
partnerships with clinical provider organizations, national
policymakers, councils, schools, faith groups, third-sector
organizations and citizens. In short, ‘impact’ is much
more than commercial spin-offs.
As the first ‘Dean for Research Impact’ appointed by a
UK higher education institution, Professor Greenhalgh
will summarise prevailing national and international
debates about what research impact is; how it should be
measured; how to balance the potentially conflicting
agendas of ‘economic’ and ‘societal’ impact; and how to
build capacity at all levels for delivering on both these
agendas.
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